Biogen Inc.
BIIB
$181.54
$0.790.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.19% | 8.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.19% | 8.82% | |||
| Cost of Revenue | -46.25% | 63.73% | |||
| Gross Profit | 19.23% | -8.30% | |||
| SG&A Expenses | 1.98% | 1.17% | |||
| Depreciation & Amortization | 6.51% | 13.95% | |||
| Other Operating Expenses | 16.27% | 29.09% | |||
| Total Operating Expenses | 1.51% | -1.10% | |||
| Operating Income | -14.96% | 34.27% | |||
| Income Before Tax | -25.09% | 139.07% | |||
| Income Tax Expenses | -16.85% | 54.46% | |||
| Earnings from Continuing Operations | -26.51% | 163.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.51% | 163.95% | |||
| EBIT | -14.96% | 34.27% | |||
| EBITDA | -11.63% | 28.30% | |||
| EPS Basic | -26.56% | 163.23% | |||
| Normalized Basic EPS | -13.21% | 32.38% | |||
| EPS Diluted | -26.79% | 164.02% | |||
| Normalized Diluted EPS | -13.39% | 32.65% | |||
| Average Basic Shares Outstanding | 0.07% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||